Loading…

Automated liquid chromatographic/tandem mass spectrometric method for screening β-blocking drugs in urine

An automated liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method is presented for the screening and confirmation of 16 β‐blocking drugs in clinical and autopsy urine samples. The described method involved C18 solid phase extraction, LC separation and MS analysis on a triple‐stage quad...

Full description

Saved in:
Bibliographic Details
Published in:Journal of mass spectrometry. 2000-07, Vol.35 (7), p.912-918
Main Authors: Gergov, M., Robson, J. N., Duchoslav, E., Ojanperä, I.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 918
container_issue 7
container_start_page 912
container_title Journal of mass spectrometry.
container_volume 35
creator Gergov, M.
Robson, J. N.
Duchoslav, E.
Ojanperä, I.
description An automated liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method is presented for the screening and confirmation of 16 β‐blocking drugs in clinical and autopsy urine samples. The described method involved C18 solid phase extraction, LC separation and MS analysis on a triple‐stage quadrupole mass analyser. Samples were initially pre‐screened for the presence of any β‐blocking drugs using LC/MS with selected ion monitoring. Any compounds tentatively identified as β‐blocking drugs on the basis of their LC retention time and protonated molecular ion were then automatedly subjected to a second analysis in which the relevant MS/MS product ion mass spectra were acquired. These product ion mass spectra were then automatically searched against a 400‐substance mass spectral library containing previously acquired β‐blocking drugs. The results demonstrated that library search of β‐blocking drugs in urine with MS/MS product ion mass spectra was more reliable and produced fewer false negatives than library searching with mass spectra derived from single‐stage quadrupole MS. The limits of identification in the MS/MS product ion scan ranged from 0.02 mg l−1 for carvedilol to 1.2 mg l−1 for pindolol, the majority of the values being below 0.2 mg l−1. Copyright © 2000 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/1096-9888(200007)35:7<912::AID-JMS19>3.0.CO;2-4
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71770225</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71770225</sourcerecordid><originalsourceid>FETCH-LOGICAL-i3489-5294a0d61b6a67a7b429f0b4e28a8013412177af9ff4dcfe81516a54a42e13073</originalsourceid><addsrcrecordid>eNpNkdtu1DAQhiMEogd4BeQLhOhFtj7FjheEtEqhFBWWigISNyOv4-y6zWFrJ4K-Fg_CM-GQpeCbGY2_-S7mTxJJ8IxgTI8JViJVeZ4_pzg-ecSyuXypCJ3PF2cn6bv3n4h6xWZ4Vixf0JTfS_bvNu6PvRRpRiTfSw5CuIoCpbh4mOxFiHHOxX5ytRj6rtG9LVHtbgZXIrPx46Bbe73dOHPc67a0DWp0CChsrenjt-29MyiWTVeiqvMoGG9t69o1-vUzXdWduR770g_rgFyLBu9a-yh5UOk62Me7eph8fvP6snibni9Pz4rFeeoYz1WaUcU1LgVZCS2klitOVYVX3NJc55gwTiiRUleqqnhpKpuTjAidcc2pJQxLdpg8m7xb390MNvTQuGBsXevWdkMAGdcxpVkEn-zAYdXYErbeNdrfwt_rRODpDtDB6LryujUu_OM4U1jRiF1M2HdX29v_NDBmOOoEjInAlCGwDCTEDCFGCH8iBAYYiiVQ4NMgOtPJ6UJvf9w5tb8GIZnM4OuHU7goOL78cvINPrLfUcijNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71770225</pqid></control><display><type>article</type><title>Automated liquid chromatographic/tandem mass spectrometric method for screening β-blocking drugs in urine</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Gergov, M. ; Robson, J. N. ; Duchoslav, E. ; Ojanperä, I.</creator><creatorcontrib>Gergov, M. ; Robson, J. N. ; Duchoslav, E. ; Ojanperä, I.</creatorcontrib><description>An automated liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method is presented for the screening and confirmation of 16 β‐blocking drugs in clinical and autopsy urine samples. The described method involved C18 solid phase extraction, LC separation and MS analysis on a triple‐stage quadrupole mass analyser. Samples were initially pre‐screened for the presence of any β‐blocking drugs using LC/MS with selected ion monitoring. Any compounds tentatively identified as β‐blocking drugs on the basis of their LC retention time and protonated molecular ion were then automatedly subjected to a second analysis in which the relevant MS/MS product ion mass spectra were acquired. These product ion mass spectra were then automatically searched against a 400‐substance mass spectral library containing previously acquired β‐blocking drugs. The results demonstrated that library search of β‐blocking drugs in urine with MS/MS product ion mass spectra was more reliable and produced fewer false negatives than library searching with mass spectra derived from single‐stage quadrupole MS. The limits of identification in the MS/MS product ion scan ranged from 0.02 mg l−1 for carvedilol to 1.2 mg l−1 for pindolol, the majority of the values being below 0.2 mg l−1. Copyright © 2000 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 1076-5174</identifier><identifier>EISSN: 1096-9888</identifier><identifier>DOI: 10.1002/1096-9888(200007)35:7&lt;912::AID-JMS19&gt;3.0.CO;2-4</identifier><identifier>PMID: 10934446</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Adrenergic beta-Antagonists - urine ; Analysis ; Automation ; Autopsy ; Biological and medical sciences ; Chromatography, Liquid - methods ; Drug Evaluation, Preclinical - methods ; General pharmacology ; Humans ; ionspray ; liquid chromatography/collision induced dissociation tandem mass spectrometry ; liquid chromatography/collision-induced dissociation mass spectrometry ; Mass Spectrometry - methods ; Medical sciences ; Pharmacology. Drug treatments ; screening ; Sensitivity and Specificity ; Software ; β-blocking drugs</subject><ispartof>Journal of mass spectrometry., 2000-07, Vol.35 (7), p.912-918</ispartof><rights>Copyright © 2000 John Wiley &amp; Sons, Ltd.</rights><rights>2000 INIST-CNRS</rights><rights>Copyright 2000 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1439092$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10934446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gergov, M.</creatorcontrib><creatorcontrib>Robson, J. N.</creatorcontrib><creatorcontrib>Duchoslav, E.</creatorcontrib><creatorcontrib>Ojanperä, I.</creatorcontrib><title>Automated liquid chromatographic/tandem mass spectrometric method for screening β-blocking drugs in urine</title><title>Journal of mass spectrometry.</title><addtitle>J. Mass Spectrom</addtitle><description>An automated liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method is presented for the screening and confirmation of 16 β‐blocking drugs in clinical and autopsy urine samples. The described method involved C18 solid phase extraction, LC separation and MS analysis on a triple‐stage quadrupole mass analyser. Samples were initially pre‐screened for the presence of any β‐blocking drugs using LC/MS with selected ion monitoring. Any compounds tentatively identified as β‐blocking drugs on the basis of their LC retention time and protonated molecular ion were then automatedly subjected to a second analysis in which the relevant MS/MS product ion mass spectra were acquired. These product ion mass spectra were then automatically searched against a 400‐substance mass spectral library containing previously acquired β‐blocking drugs. The results demonstrated that library search of β‐blocking drugs in urine with MS/MS product ion mass spectra was more reliable and produced fewer false negatives than library searching with mass spectra derived from single‐stage quadrupole MS. The limits of identification in the MS/MS product ion scan ranged from 0.02 mg l−1 for carvedilol to 1.2 mg l−1 for pindolol, the majority of the values being below 0.2 mg l−1. Copyright © 2000 John Wiley &amp; Sons, Ltd.</description><subject>Adrenergic beta-Antagonists - urine</subject><subject>Analysis</subject><subject>Automation</subject><subject>Autopsy</subject><subject>Biological and medical sciences</subject><subject>Chromatography, Liquid - methods</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>ionspray</subject><subject>liquid chromatography/collision induced dissociation tandem mass spectrometry</subject><subject>liquid chromatography/collision-induced dissociation mass spectrometry</subject><subject>Mass Spectrometry - methods</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>screening</subject><subject>Sensitivity and Specificity</subject><subject>Software</subject><subject>β-blocking drugs</subject><issn>1076-5174</issn><issn>1096-9888</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpNkdtu1DAQhiMEogd4BeQLhOhFtj7FjheEtEqhFBWWigISNyOv4-y6zWFrJ4K-Fg_CM-GQpeCbGY2_-S7mTxJJ8IxgTI8JViJVeZ4_pzg-ecSyuXypCJ3PF2cn6bv3n4h6xWZ4Vixf0JTfS_bvNu6PvRRpRiTfSw5CuIoCpbh4mOxFiHHOxX5ytRj6rtG9LVHtbgZXIrPx46Bbe73dOHPc67a0DWp0CChsrenjt-29MyiWTVeiqvMoGG9t69o1-vUzXdWduR770g_rgFyLBu9a-yh5UOk62Me7eph8fvP6snibni9Pz4rFeeoYz1WaUcU1LgVZCS2klitOVYVX3NJc55gwTiiRUleqqnhpKpuTjAidcc2pJQxLdpg8m7xb390MNvTQuGBsXevWdkMAGdcxpVkEn-zAYdXYErbeNdrfwt_rRODpDtDB6LryujUu_OM4U1jRiF1M2HdX29v_NDBmOOoEjInAlCGwDCTEDCFGCH8iBAYYiiVQ4NMgOtPJ6UJvf9w5tb8GIZnM4OuHU7goOL78cvINPrLfUcijNA</recordid><startdate>200007</startdate><enddate>200007</enddate><creator>Gergov, M.</creator><creator>Robson, J. N.</creator><creator>Duchoslav, E.</creator><creator>Ojanperä, I.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200007</creationdate><title>Automated liquid chromatographic/tandem mass spectrometric method for screening β-blocking drugs in urine</title><author>Gergov, M. ; Robson, J. N. ; Duchoslav, E. ; Ojanperä, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i3489-5294a0d61b6a67a7b429f0b4e28a8013412177af9ff4dcfe81516a54a42e13073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adrenergic beta-Antagonists - urine</topic><topic>Analysis</topic><topic>Automation</topic><topic>Autopsy</topic><topic>Biological and medical sciences</topic><topic>Chromatography, Liquid - methods</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>ionspray</topic><topic>liquid chromatography/collision induced dissociation tandem mass spectrometry</topic><topic>liquid chromatography/collision-induced dissociation mass spectrometry</topic><topic>Mass Spectrometry - methods</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>screening</topic><topic>Sensitivity and Specificity</topic><topic>Software</topic><topic>β-blocking drugs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gergov, M.</creatorcontrib><creatorcontrib>Robson, J. N.</creatorcontrib><creatorcontrib>Duchoslav, E.</creatorcontrib><creatorcontrib>Ojanperä, I.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of mass spectrometry.</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gergov, M.</au><au>Robson, J. N.</au><au>Duchoslav, E.</au><au>Ojanperä, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Automated liquid chromatographic/tandem mass spectrometric method for screening β-blocking drugs in urine</atitle><jtitle>Journal of mass spectrometry.</jtitle><addtitle>J. Mass Spectrom</addtitle><date>2000-07</date><risdate>2000</risdate><volume>35</volume><issue>7</issue><spage>912</spage><epage>918</epage><pages>912-918</pages><issn>1076-5174</issn><eissn>1096-9888</eissn><abstract>An automated liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method is presented for the screening and confirmation of 16 β‐blocking drugs in clinical and autopsy urine samples. The described method involved C18 solid phase extraction, LC separation and MS analysis on a triple‐stage quadrupole mass analyser. Samples were initially pre‐screened for the presence of any β‐blocking drugs using LC/MS with selected ion monitoring. Any compounds tentatively identified as β‐blocking drugs on the basis of their LC retention time and protonated molecular ion were then automatedly subjected to a second analysis in which the relevant MS/MS product ion mass spectra were acquired. These product ion mass spectra were then automatically searched against a 400‐substance mass spectral library containing previously acquired β‐blocking drugs. The results demonstrated that library search of β‐blocking drugs in urine with MS/MS product ion mass spectra was more reliable and produced fewer false negatives than library searching with mass spectra derived from single‐stage quadrupole MS. The limits of identification in the MS/MS product ion scan ranged from 0.02 mg l−1 for carvedilol to 1.2 mg l−1 for pindolol, the majority of the values being below 0.2 mg l−1. Copyright © 2000 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>10934446</pmid><doi>10.1002/1096-9888(200007)35:7&lt;912::AID-JMS19&gt;3.0.CO;2-4</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1076-5174
ispartof Journal of mass spectrometry., 2000-07, Vol.35 (7), p.912-918
issn 1076-5174
1096-9888
language eng
recordid cdi_proquest_miscellaneous_71770225
source Wiley-Blackwell Read & Publish Collection
subjects Adrenergic beta-Antagonists - urine
Analysis
Automation
Autopsy
Biological and medical sciences
Chromatography, Liquid - methods
Drug Evaluation, Preclinical - methods
General pharmacology
Humans
ionspray
liquid chromatography/collision induced dissociation tandem mass spectrometry
liquid chromatography/collision-induced dissociation mass spectrometry
Mass Spectrometry - methods
Medical sciences
Pharmacology. Drug treatments
screening
Sensitivity and Specificity
Software
β-blocking drugs
title Automated liquid chromatographic/tandem mass spectrometric method for screening β-blocking drugs in urine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A59%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Automated%20liquid%20chromatographic/tandem%20mass%20spectrometric%20method%20for%20screening%20%CE%B2-blocking%20drugs%20in%20urine&rft.jtitle=Journal%20of%20mass%20spectrometry.&rft.au=Gergov,%20M.&rft.date=2000-07&rft.volume=35&rft.issue=7&rft.spage=912&rft.epage=918&rft.pages=912-918&rft.issn=1076-5174&rft.eissn=1096-9888&rft_id=info:doi/10.1002/1096-9888(200007)35:7%3C912::AID-JMS19%3E3.0.CO;2-4&rft_dat=%3Cproquest_pubme%3E71770225%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i3489-5294a0d61b6a67a7b429f0b4e28a8013412177af9ff4dcfe81516a54a42e13073%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71770225&rft_id=info:pmid/10934446&rfr_iscdi=true